Riskpilot← Back to searchSign inGet full accessAPEKS FYSIOTERAPI AS
ASActiveOrg 916932022Slyngstadvegen 4, 6264 TennfjordPhysiotherapy activities · NACE 8695Est. 20162 employeeswww.apeksfysioterapi.no
Revenue 2024
NOK 1,7M
+91% vs 2023
EBITDA margin
0.0%
+100% vs 2023
Equity ratio
-41.7%
Financial strength
Net profit 2024
NOK -19K
+85% vs 2023
| Revenue | NOK 1,7M | +91% |
| EBITDA | NOK -584 | +100% |
| Net profit | NOK -19K | +85% |
| Total assets | NOK 185K | -15% |
| Equity | NOK -77K | -33% |
| Employees | 2 | — |
Legal name
APEKS FYSIOTERAPI AS
Org number
916932022
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
1. april 2016
Share capital
NOK 265 638
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drift i fellesfunksjoner i gruppepraksis i fysioterapi og virksomhet som står i forbindelse med dette. I denne sammenheng skal selve fysioterapivirksomheten drives av den enkelte deltaker og leietaker for dennes regning og risiko. Selskapet har også som formål selv å drive fysioterapitjenester, trening og annen virksomhet som står i naturlig sammenheng med dette.
Address
Slyngstadvegen 4, 6264 Tennfjord
Phone
+4770213300
Email
info@haramhelse.nhn.no
Website
www.apeksfysioterapi.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 687 | 789 | 913 | 890 | 1 697 |
| Staff expenses | −409 | −467 | −470 | −470 | −231 |
| EBITDA | 2 | −26 | 39 | −118 | −1 |
| Depreciation & amort. | −30 | −30 | −30 | −30 | −9 |
| EBIT | −28 | −56 | 9 | −148 | −10 |
| Net financials | 0 | −7 | −6 | −16 | −14 |
| Profit before tax | −28 | −63 | 2 | −165 | −24 |
| Tax | −6 | −14 | 1 | −36 | −5 |
| Net profit | −22 | −49 | 2 | −128 | −19 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 187 | 278 | 249 | 217 | 185 |
| Equity | 118 | 69 | 71 | −58 | −77 |
| Long-term debt | 0 | 135 | 105 | 180 | 140 |
| Short-term debt | 69 | 74 | 74 | 95 | 121 |
| Total debt | 69 | 209 | 179 | 275 | 261 |
EBITDA margin
-0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
-41.7%
This company
38.2%
Market median
-209% vs market
20202024
Return on equity
-1923200.0%
This company
18.4%
Market median
-10452274% vs market
20202024
Net profit margin
-1.1%
This company
8.1%
Market median
-114% vs market
20202024
Asset turnover
9.19×
This company
1.12×
Market median
+721% vs market
20202024
Debt / equity
3.40×
This company
0.62×
Market median
-448% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LA Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of APEKS FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Line Alvestad Mikalsen | Chief Executive Officer | 0 companies |
| Margareth Aasebø Løvland | Chairman | 0 companies |